Literature DB >> 14588127

Attitudes to prophylactic surgery and chemoprevention in Australian women at increased risk for breast cancer.

B Meiser1, P Butow, M Price, B Bennett, G Berry, K Tucker.   

Abstract

BACKGROUND: Because of the uncertain efficacy of breast cancer screening in women at increased risk of developing breast cancer, bilateral prophylactic oophorectomy and mastectomy are considered management options for high-risk women. Data on the attitudes to prophylactic strategies of high-risk women who have not attended specialist clinics are needed to ascertain the need for patient education and provide the basis for planning of support services.
METHODS: Three hundred seventy-one women unaffected by cancer and with unknown mutation status from families with a dominantly inherited susceptibility to breast cancer, recruited through a large Australian population-based, epidemiological study, were assessed using a mailed self-administered questionnaire with validated measures of psychological outcome.
RESULTS: Sixteen percent of women reported considering prophylactic mastectomy, and 1% had already had the procedure. Among women with a family history of breast/ovarian cancer, 33% had considered and 5% had already had a prophylactic oophorectomy. Twenty-three percent of women reported considering taking tamoxifen if it were shown to prevent breast cancer. Consideration of prophylactic oophorectomy (OR = 1.51 for a 10% change in perceived risk, 95% CI 1.14-1.99, p = 0.0045) and tamoxifen (OR = 1.14 for a 10% change in perceived risk, 95% CI 1.002-1.30, p = 0.047) were positively associated with perceived cancer risk.
CONCLUSIONS: Attitudes to prophylactic surgery and psychological distress levels in high-risk women participating in an epidemiological study appear to be comparable to those of women attending familial cancer clinics and indicate that women attending high-risk clinics may be representative of the larger population of women at increased risk.

Entities:  

Mesh:

Year:  2003        PMID: 14588127     DOI: 10.1089/154099903322447738

Source DB:  PubMed          Journal:  J Womens Health (Larchmt)        ISSN: 1540-9996            Impact factor:   2.681


  17 in total

Review 1.  Patient decisions about breast cancer chemoprevention: a systematic review and meta-analysis.

Authors:  Mary E Ropka; Jess Keim; John T Philbrick
Journal:  J Clin Oncol       Date:  2010-05-10       Impact factor: 44.544

2.  Women's views on chemoprevention of breast cancer: qualitative study.

Authors:  R Heisey; N Pimlott; M Clemons; S Cummings; N Drummond
Journal:  Can Fam Physician       Date:  2006-05       Impact factor: 3.275

3.  Psychological adjustment and knowledge about hereditary hemochromatosis in a clinic-based sample: a prospective study.

Authors:  Bettina Meiser; Stewart Dunn; Jeannette Dixon; Lawrie W Powell
Journal:  J Genet Couns       Date:  2005-12       Impact factor: 2.537

4.  Personalised Risk Prediction in Hereditary Breast and Ovarian Cancer: A Protocol for a Multi-Centre Randomised Controlled Trial.

Authors:  Stephanie Archer; Nichola Fennell; Ellen Colvin; Rozelle Laquindanum; Meredith Mills; Romy Dennis; Francisca Stutzin Donoso; Rochelle Gold; Alice Fan; Kate Downes; James Ford; Antonis C Antoniou; Allison W Kurian; D Gareth Evans; Marc Tischkowitz
Journal:  Cancers (Basel)       Date:  2022-05-31       Impact factor: 6.575

5.  Acceptance and adherence to chemoprevention among women at increased risk of breast cancer.

Authors:  Richard G Roetzheim; Ji-Hyun Lee; William Fulp; Elizabeth Matos Gomez; Elissa Clayton; Sharon Tollin; Nazanin Khakpour; Christine Laronga; Marie Catherine Lee; John V Kiluk
Journal:  Breast       Date:  2014-12-06       Impact factor: 4.380

6.  Psychosocial factors and uptake of risk-reducing salpingo-oophorectomy in women at high risk for ovarian cancer.

Authors:  Bettina Meiser; Melanie A Price; Phyllis N Butow; Janan Karatas; Judy Wilson; Louise Heiniger; Brandi Baylock; Margaret Charles; Sue-Anne McLachlan; Kelly-Anne Phillips
Journal:  Fam Cancer       Date:  2013-03       Impact factor: 2.375

7.  Misperceptions of ovarian cancer risk in women at increased risk for hereditary ovarian cancer.

Authors:  Bettina Meiser; Melanie A Price; Phyllis N Butow; Belinda Rahman; Kathy Tucker; Benjamin Cheah; Adrian Bickerstaffe; John Hopper; Kelly-Anne Phillips
Journal:  Fam Cancer       Date:  2014-06       Impact factor: 2.375

Review 8.  Women's decision making about risk-reducing strategies in the context of hereditary breast and ovarian cancer: a systematic review.

Authors:  A Fuchsia Howard; Lynda G Balneaves; Joan L Bottorff
Journal:  J Genet Couns       Date:  2009-10-03       Impact factor: 2.537

9.  Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource.

Authors:  Graham J Mann; Heather Thorne; Rosemary L Balleine; Phyllis N Butow; Christine L Clarke; Edward Edkins; Gerda M Evans; Sián Fereday; Eric Haan; Michael Gattas; Graham G Giles; Jack Goldblatt; John L Hopper; Judy Kirk; Jennifer A Leary; Geoffrey Lindeman; Eveline Niedermayr; Kelly-Anne Phillips; Sandra Picken; Gulietta M Pupo; Christobel Saunders; Clare L Scott; Amanda B Spurdle; Graeme Suthers; Kathy Tucker; Georgia Chenevix-Trench
Journal:  Breast Cancer Res       Date:  2006-02-13       Impact factor: 6.466

10.  Time to decide about risk-reducing mastectomy: a case series of BRCA1/2 gene mutation carriers.

Authors:  Mary McCullum; Joan L Bottorff; Mary Kelly; Stephanie A Kieffer; Lynda G Balneaves
Journal:  BMC Womens Health       Date:  2007-03-06       Impact factor: 2.809

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.